Compare $LUCD vs $STXS | Chartloom

Compare

$LUCD vs $STXS

Lucid Diagnostics Inc · Stereotaxis Inc

LUCD

Lucid Diagnostics Inc

STXS

Stereotaxis Inc

Compare $LUCD vs $STXS

Comparing Lucid Diagnostics Inc and Stereotaxis Inc

LUCDLucid Diagnostics Inc

STXSStereotaxis Inc

LUCDLucid Diagnostics Inc

Market cap

$122M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

13.06x

Rev growth (TTM)

24.9%

YTD performance

-43.0%

52W performance

-47.7%

FCF yield

-38.8%

STXSStereotaxis Inc

Market cap

$111M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.57x

Rev growth (TTM)

-5.5%

YTD performance

-52.2%

52W performance

-68.9%

FCF yield

-14.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LUCD

STXS

Detailed metrics comparison

LUCD

Lucid Diagnostics Inc

STXS

Stereotaxis Inc

Market Cap

LUCD$122M

STXS$111M

Enterprise Value

LUCD$112M

STXS$100M

Price

LUCD$0.64

STXS$1.11

P/E Ratio

LUCDN/A

STXSN/A

P/S Ratio

LUCD22.35x

STXS3.68x

EV/Sales

LUCD20.53x

STXS3.33x

EV/EBITDA

LUCD0.00x

STXS234.23x

P/B Ratio

LUCD11.67x

STXS6.77x

P/FCF Ratio

LUCDN/A

STXSN/A

EV/FCF

LUCD-2.37x

STXS-6.46x

PEG Ratio

LUCDN/A

STXSN/A

Forward P/E (NTM)

LUCDN/A

STXSN/A

Forward P/S (NTM)

LUCD13.06x

STXS2.57x

Revenue (TTM)

LUCD$5M

STXS$30M

Revenue Growth (YoY)

LUCD24.9%

STXS-5.5%

Forward Rev Growth

LUCD163.5%

STXS33.0%

Gross Margin (TTM)

LUCD-21.7%

STXS55.6%

Operating Margin (TTM)

LUCD0.0%

STXS0.0%

EBITDA Margin (TTM)

LUCD-914.8%

STXS-60.1%

Net Margin (TTM)

LUCD-1193.9%

STXS-78.5%

FCF Margin (TTM)

LUCD-866.6%

STXS-51.6%

Net Income (TTM)

LUCD$-65M

STXS$-24M

FCF (TTM)

LUCD$-47M

STXS$-16M

EPS (TTM)

LUCD-$0.35

STXS-$0.24

ROE (TTM)

LUCD-40434.0%

STXS-13262.0%

ROA (TTM)

LUCD-12542.0%

STXS-4304.0%

ROIC (TTM)

LUCD-14249.0%

STXS-13262.0%

Cash

LUCD$33M

STXS$10M

Debt

LUCD$24M

STXS$0

Net Cash/Debt

LUCD$10M

STXS$10M

Current Ratio (TTM)

LUCD1.33x

STXS1.42x

Quick Ratio (TTM)

LUCD1.29x

STXS0.91x

Debt/Equity (TTM)

LUCD2.15x

STXS0.00x

Debt/Assets (TTM)

LUCD0.0%

STXS0.0%

Interest Coverage (TTM)

LUCDN/A

STXSN/A

Net Debt/EBITDA (TTM)

LUCD0.00x

STXS0.00x

Beta

LUCD1.16

STXS1.40

52W Performance

LUCD-47.7%

STXS-68.9%

YTD Performance

LUCD-43.0%

STXS-52.2%

% from 52W High

LUCD-60.8%

STXS-69.1%

% from 52W Low

LUCD27.6%

STXS1.8%

Asset Turnover (TTM)

LUCD0.13x

STXS0.58x

FCF Yield (TTM)

LUCD-38.8%

STXS-14.0%

Earnings Yield (TTM)

LUCD-53.4%

STXS-21.3%

Dividend Yield (TTM)

LUCDN/A

STXSN/A

Rule of 40

LUCD-841.7

STXS-57.0

EV/GP/RG

LUCDN/A

STXS0.14

Ticker research

View LUCD research View STXS research

Metric	LUCD Lucid Diagnostics Inc	STXS Stereotaxis Inc
Market & Valuation
Market Cap	$122M	$111M
Enterprise Value	$112M	$100M
Price	$0.64	$1.11
P/E Ratio	N/A	N/A
P/S Ratio	22.35x	3.68x
EV/Sales	20.53x	3.33x
EV/EBITDA	0.00x	234.23x
P/B Ratio	11.67x	6.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.37x	-6.46x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	13.06x	2.57x
Revenue & Growth
Revenue (TTM)	$5M	$30M
Revenue Growth (YoY)	24.9%	-5.5%
Forward Rev Growth	163.5%	33.0%
Profitability
Gross Margin (TTM)	-21.7%	55.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-914.8%	-60.1%
Net Margin (TTM)	-1193.9%	-78.5%
FCF Margin (TTM)	-866.6%	-51.6%
Net Income (TTM)	$-65M	$-24M
FCF (TTM)	$-47M	$-16M
EPS (TTM)	-$0.35	-$0.24
ROE (TTM)	-40434.0%	-13262.0%
ROA (TTM)	-12542.0%	-4304.0%
ROIC (TTM)	-14249.0%	-13262.0%
Financial Health
Cash	$33M	$10M
Debt	$24M	$0
Net Cash/Debt	$10M	$10M
Current Ratio (TTM)	1.33x	1.42x
Quick Ratio (TTM)	1.29x	0.91x
Debt/Equity (TTM)	2.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.16	1.40
52W Performance	-47.7%	-68.9%
YTD Performance	-43.0%	-52.2%
% from 52W High	-60.8%	-69.1%
% from 52W Low	27.6%	1.8%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.58x
FCF Yield (TTM)	-38.8%	-14.0%
Earnings Yield (TTM)	-53.4%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-841.7	-57.0
EV/GP/RG	N/A	0.14
Ticker research	View LUCD research	View STXS research

Valuation

P/S Ratio

STXS

3.68x

LUCD

22.35x

EV/FCF

STXS

-6.46x

LUCD

-2.37x

Growth & revenue

Revenue Growth TTM

LUCD

24.9%

STXS

-5.5%

Forward Revenue Growth

LUCD

163.5%

STXS

33.0%

Profitability & performance

Gross Margin

STXS

55.6%

LUCD

-21.7%

ROE

STXS

-13262.0%

LUCD

-40434.0%

FCF Yield %

STXS

-14.0%

LUCD

-38.8%

52-Week Performance

LUCD

-47.7%

STXS

-68.9%

Detailed metrics comparison

LUCD

Lucid Diagnostics Inc

STXS

Stereotaxis Inc

Market Cap

LUCD$122M

STXS$111M

Enterprise Value

LUCD$112M

STXS$100M

Price

LUCD$0.64

STXS$1.11

P/E Ratio

LUCDN/A

STXSN/A

P/S Ratio

LUCD22.35x

STXS3.68x

EV/Sales

LUCD20.53x

STXS3.33x

EV/EBITDA

LUCD0.00x

STXS234.23x

P/B Ratio

LUCD11.67x

STXS6.77x

P/FCF Ratio

LUCDN/A

STXSN/A

EV/FCF

LUCD-2.37x

STXS-6.46x

PEG Ratio

LUCDN/A

STXSN/A

Forward P/E (NTM)

LUCDN/A

STXSN/A

Forward P/S (NTM)

LUCD13.06x

STXS2.57x

Revenue (TTM)

LUCD$5M

STXS$30M

Revenue Growth (YoY)

LUCD24.9%

STXS-5.5%

Forward Rev Growth

LUCD163.5%

STXS33.0%

Gross Margin (TTM)

LUCD-21.7%

STXS55.6%

Operating Margin (TTM)

LUCD0.0%

STXS0.0%

EBITDA Margin (TTM)

LUCD-914.8%

STXS-60.1%

Net Margin (TTM)

LUCD-1193.9%

STXS-78.5%

FCF Margin (TTM)

LUCD-866.6%

STXS-51.6%

Net Income (TTM)

LUCD$-65M

STXS$-24M

FCF (TTM)

LUCD$-47M

STXS$-16M

EPS (TTM)

LUCD-$0.35

STXS-$0.24

ROE (TTM)

LUCD-40434.0%

STXS-13262.0%

ROA (TTM)

LUCD-12542.0%

STXS-4304.0%

ROIC (TTM)

LUCD-14249.0%

STXS-13262.0%

Cash

LUCD$33M

STXS$10M

Debt

LUCD$24M

STXS$0

Net Cash/Debt

LUCD$10M

STXS$10M

Current Ratio (TTM)

LUCD1.33x

STXS1.42x

Quick Ratio (TTM)

LUCD1.29x

STXS0.91x

Debt/Equity (TTM)

LUCD2.15x

STXS0.00x

Debt/Assets (TTM)

LUCD0.0%

STXS0.0%

Interest Coverage (TTM)

LUCDN/A

STXSN/A

Net Debt/EBITDA (TTM)

LUCD0.00x

STXS0.00x

Beta

LUCD1.16

STXS1.40

52W Performance

LUCD-47.7%

STXS-68.9%

YTD Performance

LUCD-43.0%

STXS-52.2%

% from 52W High

LUCD-60.8%

STXS-69.1%

% from 52W Low

LUCD27.6%

STXS1.8%

Asset Turnover (TTM)

LUCD0.13x

STXS0.58x

FCF Yield (TTM)

LUCD-38.8%

STXS-14.0%

Earnings Yield (TTM)

LUCD-53.4%

STXS-21.3%

Dividend Yield (TTM)

LUCDN/A

STXSN/A

Rule of 40

LUCD-841.7

STXS-57.0

EV/GP/RG

LUCDN/A

STXS0.14

Ticker research

View LUCD research View STXS research

Metric	LUCD Lucid Diagnostics Inc	STXS Stereotaxis Inc
Market & Valuation
Market Cap	$122M	$111M
Enterprise Value	$112M	$100M
Price	$0.64	$1.11
P/E Ratio	N/A	N/A
P/S Ratio	22.35x	3.68x
EV/Sales	20.53x	3.33x
EV/EBITDA	0.00x	234.23x
P/B Ratio	11.67x	6.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.37x	-6.46x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	13.06x	2.57x
Revenue & Growth
Revenue (TTM)	$5M	$30M
Revenue Growth (YoY)	24.9%	-5.5%
Forward Rev Growth	163.5%	33.0%
Profitability
Gross Margin (TTM)	-21.7%	55.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-914.8%	-60.1%
Net Margin (TTM)	-1193.9%	-78.5%
FCF Margin (TTM)	-866.6%	-51.6%
Net Income (TTM)	$-65M	$-24M
FCF (TTM)	$-47M	$-16M
EPS (TTM)	-$0.35	-$0.24
ROE (TTM)	-40434.0%	-13262.0%
ROA (TTM)	-12542.0%	-4304.0%
ROIC (TTM)	-14249.0%	-13262.0%
Financial Health
Cash	$33M	$10M
Debt	$24M	$0
Net Cash/Debt	$10M	$10M
Current Ratio (TTM)	1.33x	1.42x
Quick Ratio (TTM)	1.29x	0.91x
Debt/Equity (TTM)	2.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.16	1.40
52W Performance	-47.7%	-68.9%
YTD Performance	-43.0%	-52.2%
% from 52W High	-60.8%	-69.1%
% from 52W Low	27.6%	1.8%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.58x
FCF Yield (TTM)	-38.8%	-14.0%
Earnings Yield (TTM)	-53.4%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-841.7	-57.0
EV/GP/RG	N/A	0.14
Ticker research	View LUCD research	View STXS research